Masashi Matsuda
Kanagawa, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Extending the residence period of allogeneic iPSC-derived invariant natural killer T cells in humanized mice by editing HLA class I expression.
Journal: Frontiers in cell and developmental biology
Published: April 30, 2026
Immunoglobulin constant domains as targets for T-cell receptor-based treatment of multiple myeloma.
Journal: Blood
Published: December 09, 2025
Preclinical efficacy of combination therapy with allogeneic induced pluripotent stem cell-derived invariant natural killer T and α-galactosylceramide-pulsed antigen-presenting cells.
Journal: Stem cell research & therapy
Published: July 12, 2025
The role of IL-4+ memory T cells in SARS-CoV-2 booster vaccination.
Journal: International immunology
Published: June 23, 2025
A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemia.
Journal: Leukemia
Published: June 14, 2025
Monoclonal antibodies against human TMPRSS2 prevent infection by any SARS-CoV-2 variant.
Journal: iScience
Published: January 18, 2025
TCR-Based Therapy Directed against Kallikrein-Related Peptidase 4 Is Safe and Effective against Prostate Cancer.
Journal: Cancer immunology research
Published: January 14, 2025
SETBP1 is dispensable for normal and malignant hematopoiesis.
Journal: Leukemia
Published: November 21, 2022
Intracellular virus sensor MDA5 mutation develops autoimmune myocarditis and nephritis.
Journal: Journal of autoimmunity
Published: December 07, 2021
Deficiency of TMEM53 causes a previously unknown sclerosing bone disorder by dysregulation of BMP-SMAD signaling.
Journal: Nature communications
Published: October 01, 2020
Last Updated: 09/26/2026